Massiel Pedreira

Massiel Pedreira

Proskauer Rose LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

SEC Focus on Disclosure Issues for Municipal Securities, Private Equity and ETFs

At the recent Columbia Law School Conference, “Hot Topics: Leading Current Issues in Securities Regulation and Enforcement,” SEC Commissioner Kara M. Stein’s keynote address focused on a number of transparency and disclosure...more

12/3/2014 - Corporate Governance Disclosure Requirements ETFs Municipal Securities Issuers Private Equity SEC Transparency

Justices Scalia and Thomas Amenable to Reexamining Deference to SEC Statutory Interpretations

Like Prince Charming searching for the foot that fit the glass slipper, Justice Scalia recently issued a statement advising that he and Justice Thomas would be receptive to granting certiorari to a petition properly...more

12/1/2014 - Agency Deference Certiorari Convictions Corporate Crimes Justice Scalia Justice Thomas SCOTUS SEC

Firms Have Roadmap for Expanding Litigation of Customer Disputes After Second Circuit Holds Forum Selection Clauses Trump FINRA’s...

In the recent decision, Goldman Sachs & Co. v. Golden Empire Sch. Fin. Auth., 764 F.3d 210 (2d Cir. 2014), the Second Circuit held that nearly-identical forum selection clauses in broker-dealer agreements between the...more

11/24/2014 - Broker-Dealer FINRA Forum Selection Clause Goldman Sachs Mandatory Arbitration Clauses

SEC Inadvertently Produces Whistleblower Complaint, But Then Obtains Protective Relief

During discovery in an SEC administrative and cease-and-desist proceeding instituted in December 2012 (pursuant to Sections 9(b) and 9(f) of the Investment Company Act of 1940)[1] the SEC Division of Enforcement (DOE)...more

3/11/2013 - Attorney-Client Privilege Discovery SEC Whistleblowers

DOJ Recovers Up To $48 Million in False Claim Act Case Resulting From Whistleblower Report

In yet another large recovery for the DOJ, on December 6, 2012, DFB Pharmaceuticals, and its subsidiary, Healthpoint Ltd., agreed as part of a settlement to pay up to $48 million to resolve allegations that Healthpoint caused...more

1/24/2013 - DOJ False Claims Act Medicaid Medicare Pharmaceutical Qui Tam Whistleblowers

2/3 Of DOJ’s Nearly $5 Billion Recovery Under False Claims Act Derived From Whistleblower Suits in 2012

On December 4, the Justice Department announced a record-breaking recovery of $4.9 billion in settlements and judgments in civil cases brought under the False Claims Act (FCA) for the fiscal year ending September 20, 2012....more

12/11/2012 - False Claims Act Qui Tam Whistleblowers

6 Results
|
View per page
Page: of 1